
England Approves First New Ovarian Cancer Drug in 20 Years
Hundreds of women with chemotherapy-resistant ovarian cancer in England now have access to a groundbreaking treatment that extends life and shrinks tumors. It's the first new option approved for this hard-to-treat cancer in two decades.














